動態

• 

  Mary Grace N. Tamio   shared news

  在 November 13 2024 at 01:46 PM 已編輯 public

  Compatibility of hypokalaemia caused by low-dose prednisolone plus abiraterone acetate therapy for metastatic castration-resistant prostate cancer
  
  #hypokalaemia #prostatecancer #journals #articles
  
  More info | ⬇️

  

  Compatibility of hypokalaemia caused by low-dose prednisolone plus abiraterone acetate therapy for metastatic castration-resistant prostate cancer

  This study aimed to investigate the relationship between low-dose prednisolone (PSL) and the incidence of hypokalaemia at ...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 September 04 2024 at 08:00 PM 已編輯 public

  PSMA PET/CT imaging and its application to prostate cancer treatment
  
  #CTimaging #prostatecancer #journals #articles
  
  More info | ⬇️

  

  PSMA PET/CT imaging and its application to prostate cancer treatment

  Recognition of the importance of prostate-specific membrane antigen (PSMA) PET/CT in the diagnosis of prostate cancer has ...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 July 28 2024 at 07:29 PM 已編輯 public

  Failure to progress: breast and prostate cancer cell lines in developing targeted therapies
  
  #breastcancer #prostatecancer #journals #articles
  
  More info | ⬇️

  

  Failure to progress: breast and prostate cancer cell lines in developing targeted therapies

  Developing anticancer drugs from preclinical to clinical takes approximately a decade in a cutting-edge biomedical lab and...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 February 07 2024 at 07:59 PM 已編輯 public

  Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer
  
  #prostatecancer #celladhesion #journals #articles
  
  More info | ⬇️

  

  Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer

  About 30% of Prostate cancer (PCa) patients progress to metastatic PCa that remains largely incurable. This evidence under...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 January 10 2024 at 09:30 PM 已編輯 public

  Response to the letter to editor: Neurocognitive deficits attributed to androgen deprivation therapy in patients with prostate cancer should be reconsidered
  
  #androgendeprivationtherapy #prostatecancer #journals #articles
  
  More info | ⬇️

  

  Response to the letter to editor: Neurocognitive deficits attributed to androgen deprivation therapy in patients with prostate cancer should be reconsidered

  Cite this articleIhrig, A., Pernt, P.M., Zschäbitz, S. et al. Response to the letter to editor: Neurocognitive deficits at...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享